Top 10 Companies in the Global Menadione (Vitamin K3) Market (2026): Market Leaders Powering Global Nutrition

MARKET INSIGHTS

Global Menadione (Vitamin K3) Market was valued at USD 125 million in 2024. The market is projected to grow from USD 132 million in 2025 to USD 185 million by 2032, exhibiting a CAGR of 4.9% during the forecast period.

Menadione, commonly known as Vitamin K3, is a synthetic form of vitamin K that plays a vital role in blood coagulation and bone metabolism. It functions as a provitamin, converting to the active form menaquinone in the body, and is widely utilized in animal feed to prevent deficiency‑related hemorrhages and support overall livestock health. The compound is available in various forms, including MSB (menadione sodium bisulfite), MNB (menadione nicotinamide bisulfite), and MPB (menadione dimethylpyrimidinol bisulfite), each offering different stability and bioavailability profiles.

The market growth is primarily driven by the expanding animal feed industry, increasing demand for meat and dairy products, and heightened awareness of livestock nutrition. However, regulatory scrutiny regarding its use in human pharmaceuticals due to potential toxicity concerns has limited its application primarily to veterinary and animal health sectors. Key players such as Dirox, Oxyvit, and Brother Enterprises continue to innovate in production processes to enhance purity and cost‑efficiency, supporting steady market expansion despite these challenges.

Global Menadione (Vitamin K3) Market – View in Detailed Research Report

Top 10 Companies in the Global Menadione (Vitamin K3) Market (2026)

🔟 1. Dirox (China)

Headquarters: Shanghai, China
Key Offering: Bulk MSB Menadione, specialty blends for animal feed and pharmaceutical applications

Dirox has established a high‑volume production line that integrates advanced purification steps, reducing impurities that can affect feed efficacy. The company’s focus on modular manufacturing allows rapid scale‑up in response to market demand spikes.

Sustainability & Growth Initiatives:

• Investing in biocatalytic synthesis to lower solvent usage.
• Implementing closed‑loop water recycling in the plant.
• Partnering with universities for feed‑nutrient optimization research.

🟥 2. BASF (Germany)

Headquarters: Ludwigshafen, Germany
Key Offering: High‑purity MSB and MNB derivatives for pharmaceutical and feed sectors

BASF leverages its global R&D network to deliver menadione products that meet stringent regulatory standards, especially for injectable formulations. The company’s integrated supply chain ensures consistent quality across regions.

Sustainability & Growth Initiatives:

• Adopting renewable energy sources for production facilities.
• Developing low‑emission synthesis routes.
• Expanding collaborations with feed manufacturers to co‑develop targeted additives.

🟨 3. DSM (Netherlands)

Headquarters: Heerlen, Netherlands
Key Offering: MSB Menadione for animal nutrition and functional feed additives

DSM’s focus on precision nutrition has positioned it as a preferred supplier for feed manufacturers seeking to enhance growth performance and bone health in livestock.

Sustainability & Growth Initiatives:

• Investing in green chemistry to reduce chemical waste.
• Implementing digital twins to optimize process yield.
• Expanding product portfolio to include micronutrient‑enriched blends.

🟢 4. Evonik Industries (Germany)

Headquarters: Essen, Germany
Key Offering: Specialty MNB and MPB derivatives for high‑value feed and pharmaceutical markets

Evonik’s niche focus on specialty menadione derivatives allows it to capture premium pricing in segments demanding high solubility and stability.

Sustainability & Growth Initiatives:

• Deploying bio‑based solvents in synthesis.
• Enhancing product traceability through blockchain.
• Collaborating with animal health research institutes.

🟣 5. Oxyvit (South Korea)

Headquarters: Seoul, South Korea
Key Offering: Pharmaceutical‑grade menadione for injectable formulations

Oxyvit’s agility in adopting emerging regulatory standards has enabled rapid entry into high‑margin therapeutic markets.

Sustainability & Growth Initiatives:

• Implementing zero‑waste manufacturing processes.
• Partnering with local universities for process innovation.
• Expanding into functional feed blends for aquaculture.

🟠 6. Vanetta (Italy)

Headquarters: Milan, Italy
Key Offering: Specialty MPB menadione for niche feed applications

Vanetta’s focus on high‑performance additives has carved a niche among premium livestock producers.

Sustainability & Growth Initiatives:

• Adopting renewable energy for production.
• Developing eco‑friendly packaging solutions.
• Engaging in joint ventures with feed manufacturers.

🟤 7. Eastman Chemical (USA)

Headquarters: Kingsport, Tennessee, USA
Key Offering: Bulk MSB menadione for animal feed and nutraceuticals

Eastman’s robust distribution network ensures timely delivery to feed mills across North America.

Sustainability & Growth Initiatives:

• Investing in green chemistry research.
• Reducing carbon footprint through energy‑efficient processes.
• Collaborating with feed producers on formulation development.

🔵 8. Jiangsu Hengrui Medicine (China)

Headquarters: Nanjing, China
Key Offering: Pharmaceutical‑grade MNB menadione for injectable use

Hengrui’s strong foothold in the Chinese market positions it as a key supplier for domestic pharmaceutical manufacturers.

Sustainability & Growth Initiatives:

• Implementing waste‑to‑energy systems.
• Enhancing process safety protocols.
• Expanding into functional feed applications.

🟧 9. Peace Chemical (China)

Headquarters: Shenzhen, China
Key Offering: Cost‑effective MSB menadione for emerging markets

Peace Chemical’s focus on price competitiveness has driven market penetration in price‑sensitive regions of Asia‑Pacific and Latin America.

Sustainability & Growth Initiatives:

• Adopting low‑energy synthesis routes.
• Partnering with local feed mills for joint product development.
• Implementing quality management systems aligned with ISO 9001.

🟡 10. Brother Enterprises (Japan)

Headquarters: Tokyo, Japan
Key Offering: High‑purity menadione for veterinary pharmaceuticals

Brother Enterprises has leveraged its expertise in veterinary drug formulation to secure contracts with major animal health companies.

Sustainability & Growth Initiatives:

• Investing in renewable energy for production plants.
• Implementing advanced waste‑reduction technologies.
• Collaborating with research institutes on new feed additive applications.

Download FREE Sample Report

Get Full Report

🌍 Outlook: The Future of Global Menadione (Vitamin K3) Market

Feed remains the dominant application, driven by rising demand for high‑quality livestock products in emerging economies. Pharmaceutical use is expanding in niche therapeutic areas, while nutraceuticals and functional foods are carving out new revenue streams.

Key market dynamics include:

• Accelerated adoption of green synthesis routes.
• Growing emphasis on high‑purity grades to meet stringent regulatory requirements.
• Strategic partnerships between feed manufacturers and menadione suppliers to co‑develop targeted additives.
• Investment in digital platforms for supply‑chain transparency and traceability.

📈 Key Trends Shaping the Market

• Integration of menadione into functional beverages and fortified foods.
• Advances in genomics enabling personalized nutrition solutions.
• Expansion of plant‑nutrition applications, particularly in chlorophyll synthesis and crop yield enhancement.
• Increased focus on sustainable manufacturing, including biocatalytic routes and renewable energy adoption.

These developments collectively position the global Menadione (Vitamin K3) market for steady growth, with opportunities for players that combine technical innovation, regulatory compliance, and sustainability.